Effects of the b-blockers on the functional state of patients with ventricular arrhythmias
https://doi.org/10.26442/2075082X.2021.1.200246
Abstract
About the Authors
I. Z. ShubitidzeRussian Federation
V. G. Tregubov
Russian Federation
References
1. Treshkur TV, Tulintseva TE, Parmon EV, et al. Konservativnaia terapiia neishemicheskikh zheludochkovykh aritmii: opyt i perspektiva. Kardiologiia i serdechno-sosudistaia khirurgiia. 2013; 6 (5): 58–66 (in Russian)
2. Schleifer JW, Sorajja D, Shen WK. Advances in the pharmacologic treatment of ventricular arrhythmias. Expert Opin Pharmacother 2015; 16 (17): 2637–51. doi: 10.1517/14656566.2015.1100170
3. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2015; 36 (41): 2793–867. doi: 10.1714/2174.23496
4. Tarasov AV. Antiarrhythmic therapy safety issues. Consilium Medicum. 2014; 16 (10): 44–9 (in Russian)
5. Geregei AM, Kovalev AS, Vetriakov OV, et al. Sovremennye metody otsenki funktsional’nogo sostoianiia organizma i fizicheskoi rabotosposobnosti voennosluzhashchego pri reshenii nauchno-issledovatel’skikh zadach biomeditsinskoi napravlennosti. Vestn. Ros. voenno-med. akademii. 2018; 2 (62): 202–8 (in Russian)
6. Pokrovskii VM. Alternative view of the mechanism of cardiac rhythmogenesis. Heart Lung Circ 2003; 12 (1): 18–24. doi: 10.1046/j.1444-2892.2003.00192
7. Pokrovskii VM, Polischuk LV. Cardiorespiratory synchronism in estimation of regulatory and adaptive organism status. J Integr Neurosci 2016; 15 (1): 19–35. doi: 10.1142/s0219635216500060
8. Pokrovsky VM, Ponomarev VV, Artyushkov VV, et al. System for determining the cardiorespiratory synchronism in humans. Russia, 2009; Patent No. 86860 (in Russian)
9. Prokof’ev AB. Vliianie antiaritmicheskikh lekarstvennykh preparatov na kachestvo zhizni bol’nykh s narusheniiami serdechnogo ritma. Lekarstvennye preparaty i ratsional’naia farmakoterapiia. 2013; 1: 39–44 (in Russian)
10. Minushkina LO. Bisoprolol: vozmozhnosti v lechenii arterial’noi gipertonii. Kardiologiia. 2012; 52 (6): 80–5 (in Russian)
11. Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, et al. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial. Eur J Heart Fail 2011; 13 (7): 765–72. doi: 10.1093/eurjhf/hfr051
12. Toblli JE, DiGennaro F, Giani JF, et al. Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag 2012; 8: 151–60. doi: 10.2147/vhrm.S20669
13. Шубик Ю.В., Чирейкин Л.В. Соталол в лечении аритмий. Вестн. аритмологии. 1998; 10: 80–3 [Shubik IuV, Chireikin LV. Sotalol v lechenii aritmii. Vestn. aritmologii. 1998; 10: 80–3 (in Russian)].
14. Tregubov VG, Makukhin VV, Fokina KS, et al. Otsenka reguliatorno-adaptivnykh vozmozhnostei u patsientov s zheludochkovymi narusheniiami ritma serdtsa. Kubanskii nauchnyi med. vestn. 2006; 9: 66–8 (in Russian)
15. Pokrovsky VM. Cardiorespiratory synchronism in assessing the body’s regulatory and adaptive capabilities. Krasnodar: Kuban-Kniga, 2010, p. 244 (in Russian)
16.
Review
For citations:
Shubitidze I.Z., Tregubov V.G. Effects of the b-blockers on the functional state of patients with ventricular arrhythmias. Systemic Hypertension. 2021;18(1):19-24. (In Russ.) https://doi.org/10.26442/2075082X.2021.1.200246
JATS XML

























